Abstract
To commemorate Transgenic Animal Research Conference X, this review summarizes the recent progress in developing genetically engineered livestock species as biomedical models. The first of these conferences was held in 1997, which turned out to be a watershed year for the field, with two significant events occurring. One was the publication of the first transgenic livestock animal disease model, a pig with retinitis pigmentosa. Before that, the use of livestock species in biomedical research had been limited to wild-type animals or disease models that had been induced or were naturally occurring. The second event was the report of Dolly, a cloned sheep produced by somatic cell nuclear transfer. Cloning subsequently became an essential part of the process for most of the models developed in the last 18 years and is stilled used prominently today. This review is intended to highlight the biomedical modeling achievements that followed those key events, many of which were first reported at one of the previous nine Transgenic Animal Research Conferences. Also discussed are the practical challenges of utilizing livestock disease models now that the technical hurdles of model development have been largely overcome.
Similar content being viewed by others
References
Al-Mashhadi RH et al (2013) Familial hypercholesterolemia and atherosclerosis in cloned minipigs created by DNA transposition of a human PCSK9 gain-of-function mutant. Sci Transl Med 5:166ra161. doi:10.1126/scitranslmed.3004853
Baxa M et al (2013) A transgenic minipig model of Huntington’s disease. J Huntingt Dis 2:47–68. doi:10.3233/JHD-130001
Beraldi R et al (2015) A novel porcine model of ataxia telangiectasia reproduces neurological features and motor deficits of human disease. Hum Mol Genet. doi:10.1093/hmg/ddv356
Boillee S, Vande Velde C, Cleveland DW (2006) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52:39–59. doi:10.1016/j.neuron.2006.09.018
Bolton-Maggs PH, Pasi KJ (2003) Haemophilias A and B. Lancet 361:1801–1809. doi:10.1016/S0140-6736(03)13405-8
Brautbar A, Leary E, Rasmussen K, Wilson DP, Steiner RD, Virani S (2015) Genetics of familial hypercholesterolemia. Curr Atheroscler Rep 17:491. doi:10.1007/s11883-015-0491-z
Chandler MJ, Smith PJ, Samuelson DA, MacKay EO (1999) Photoreceptor density of the domestic pig retina. Vet Ophthalmol 2:179–184
Chieppa MN et al (2014) Modeling amyotrophic lateral sclerosis in hSOD1 transgenic swine. Neuro Degener Dis 13:246–254. doi:10.1159/000353472
Dai Y et al (2002) Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 20:251–255
Daiger SP, Bowne SJ, Sullivan LS (2014) Genes and mutations causing autosomal dominant retinitis pigmentosa. Cold Spring Harbor Perspect Med. doi:10.1101/cshperspect.a017129
Davis BT et al (2014) Targeted disruption of LDLR causes hypercholesterolemia and atherosclerosis in Yucatan miniature pigs. PLoS One 9:e93457. doi:10.1371/journal.pone.0093457
Dixon JL, Stoops JD, Parker JL, Laughlin MH, Weisman GA, Sturek M (1999) Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet. Arterioscl Thromb Vasc Biol 19:2981–2992
Flisikowska T et al (2012) A porcine model of familial adenomatous polyposis. Gastroenterology 143(1173–1175):e1171–e1177. doi:10.1053/j.gastro.2012.07.110
Fodde R, Smits R, Clevers H (2001) APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 1:55–67. doi:10.1038/35094067
George AL Jr (2014) Recent genetic discoveries implicating ion channels in human cardiovascular diseases. Curr Opin Pharmacol 15:47–52. doi:10.1016/j.coph.2013.11.011
Goldstein JL, Brown MS (2015) A century of cholesterol and coronaries: from plaques to genes to statins. Cell 161:161–172. doi:10.1016/j.cell.2015.01.036
Gong J et al (2014) Activating the expression of human K-rasG12D stimulates oncogenic transformation in transgenic goat fetal fibroblast cells. PLoS One 9:e90059. doi:10.1371/journal.pone.0090059
Grubb BR, Boucher RC (1999) Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol Rev 79:S193–S214
Hamel CP (2007) Cone rod dystrophies. Orphanet J Rare Dis 2:7. doi:10.1186/1750-1172-2-7
Hammer RE et al (1985) Production of transgenic rabbits, sheep and pigs by microinjection. Nature 315:680–683
He J et al (2015) PKD1 mono-allelic knockout is sufficient to trigger renal cystogenesis in a mini-pig model. Int J Biol Sci 11:361–369. doi:10.7150/ijbs.10858
Hickey RD et al (2011) Efficient production of Fah-null heterozygote pigs by chimeric adeno-associated virus-mediated gene knockout and somatic cell nuclear transfer. Hepatology 54:1351–1359. doi:10.1002/hep.24490
Hickey RD et al (2014) Fumarylacetoacetate hydrolase deficient pigs are a novel large animal model of metabolic liver disease. Stem Cell Res 13:144–153. doi:10.1016/j.scr.2014.05.003
Hoegger MJ et al (2014) Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis. Science 345:818–822. doi:10.1126/science.1255825
Horton JD, Cohen JC, Hobbs HH (2009) PCSK9: a convertase that coordinates LDL catabolism. J Lipid Res 50(Suppl):S172–S177. doi:10.1194/jlr.R800091-JLR200
Huang J et al (2014) RAG1/2 knockout pigs with severe combined immunodeficiency. J Immunol 193:1496–1503. doi:10.4049/jimmunol.1400915
Igarashi P, Somlo S (2002) Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol 13:2384–2398
Jacobsen JC et al (2010) An ovine transgenic Huntington’s disease model. Hum Mol Genet 19:1873–1882. doi:10.1093/hmg/ddq063
Jakobsen JE et al (2013) Generation of minipigs with targeted transgene insertion by recombinase-mediated cassette exchange (RMCE) and somatic cell nuclear transfer (SCNT). Transgenic Res 22:709–723. doi:10.1007/s11248-012-9671-6
Johnson CD, Davidson BL (2010) Huntington’s disease: progress toward effective disease-modifying treatments and a cure. Hum Mol Genet 19:R98–R102. doi:10.1093/hmg/ddq148
Jolly RD, Martinus RD, Palmer DN (1992) Sheep and other animals with ceroid-lipofuscinoses: their relevance to Batten disease. Am J Med Genet 42:609–614. doi:10.1002/ajmg.1320420436
Karageorgos L, Lancaster MJ, Nimmo JS, Hopwood JJ (2011) Gaucher disease in sheep. J Inherit Metab Dis 34:209–215. doi:10.1007/s10545-010-9230-3
Kashiwakura Y et al (2012) Porcine model of hemophilia A. PLoS One 7:e49450. doi:10.1371/journal.pone.0049450
Kim YJ et al (2014) Targeted disruption of Ataxia-telangiectasia mutated gene in miniature pigs by somatic cell nuclear transfer. Biochem Biophys Res Commun 452:901–905. doi:10.1016/j.bbrc.2014.08.125
Klymiuk N et al (2012) Sequential targeting of CFTR by BAC vectors generates a novel pig model of cystic fibrosis. J Mol Med 90:597–608. doi:10.1007/s00109-011-0839-y
Klymiuk N et al (2013) Dystrophin-deficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle. Hum Mol Genet 22:4368–4382. doi:10.1093/hmg/ddt287
Kostic C et al (2013) Rapid cohort generation and analysis of disease spectrum of large animal model of cone dystrophy. PLoS One 8:e71363. doi:10.1371/journal.pone.0071363
Kragh PM et al (2009) Hemizygous minipigs produced by random gene insertion and handmade cloning express the Alzheimer’s disease-causing dominant mutation APPsw. Transgenic Res 18:545–558. doi:10.1007/s11248-009-9245-4
Lai L et al (2002) Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 295:1089–1092
Lavin MF (2008) Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol 9:759–769. doi:10.1038/nrm2514
Lee K et al (2014) Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency. Proc Natl Acad Sci USA 111:7260–7265. doi:10.1073/pnas.1406376111
Leuchs S et al (2012) Inactivation and inducible oncogenic mutation of p53 in gene targeted pigs. PLoS One 7:e43323. doi:10.1371/journal.pone.0043323
Levine AJ, Oren M (2009) The first 30 years of p53: growing ever more complex. Nat Rev Cancer 9:749–758. doi:10.1038/nrc2723
Li ZY, Wong F, Chang JH, Possin DE, Hao Y, Petters RM, Milam AH (1998) Rhodopsin transgenic pigs as a model for human retinitis pigmentosa. Invest Ophthalmol Vis Sci 39:808–819
Li S et al (2015) Viable pigs with a conditionally-activated oncogenic KRAS mutation. Transgenic Res. doi:10.1007/s11248-015-9866-8
Lorson MA, Spate LD, Samuel MS, Murphy CN, Lorson CL, Prather RS, Wells KD (2011) Disruption of the survival motor neuron (SMN) gene in pigs using ssDNA. Transgenic Res 20:1293–1304. doi:10.1007/s11248-011-9496-8
Luo Y et al (2011) High efficiency of BRCA1 knockout using rAAV-mediated gene targeting: developing a pig model for breast cancer. Transgenic Res 20:975–988. doi:10.1007/s11248-010-9472-8
Luo Y, Bolund L, Sorensen CB (2012) Pig gene knockout by rAAV-mediated homologous recombination: comparison of BRCA1 gene knockout efficiency in Yucatan and Gottingen fibroblasts with slightly different target sequences. Transgenic Res 21:671–676. doi:10.1007/s11248-011-9563-1
Marshall M (1979) Induction of chronic diabetes by streptozotocin in the miniature pig Research in experimental medicine Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller. Chirurgie 175:187–196
McCreath KJ, Howcroft J, Campbell KH, Colman A, Schnieke AE, Kind AJ (2000) Production of gene-targeted sheep by nuclear transfer from cultured somatic cells. Nature 405:1066–1069
Mickelsen S, Dudley B, Treat E, Barela J, Omdahl J, Kusumoto F (2005) Survey of physician experience, trends and outcomes with atrial fibrillation ablation. J Interv Card Electrophysiol 12:213–220. doi:10.1007/s10840-005-0621-6
Morton AJ, Howland DS (2013) Large genetic animal models of Huntington’s Disease. J Huntingt Dis 2:3–19. doi:10.3233/JHD-130050
Nerbonne JM (2014) Mouse models of arrhythmogenic cardiovascular disease: challenges and opportunities. Curr Opin Pharmacol 15:107–114. doi:10.1016/j.coph.2014.02.003
Nichols KE, Malkin D, Garber JE, Fraumeni JF Jr, Li FP (2001) Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive. Oncology 10:83–87
Oetting WS (2000) The tyrosinase gene and oculocutaneous albinism type 1 (OCA1): a model for understanding the molecular biology of melanin formation. Pigment Cell Res 13:320–325
Park DS et al (2015) Genetically engineered SCN5A mutant pig hearts exhibit conduction defects and arrhythmias. J Clin Invest 125:403–412. doi:10.1172/JCI76919
Petters RM et al (1997) Genetically engineered large animal model for studying cone photoreceptor survival and degeneration in retinitis pigmentosa. Nat Biotechnol 15:965–970
Pezzulo AA et al (2012) Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature 487:109–113. doi:10.1038/nature11130
Piedrahita JA (2000) Targeted modification of the domestic animal genome. Theriogenology 53:105–116
Polejaeva IA (2013) Transgenic goat models to study cardiac fibrosis and atrial fibrillation. Paper presented at the Transgenic Animal Research Conference IX, Tahoe City, CA
Prather RS, Lorson M, Ross JW, Whyte JJ, Walters E (2013) Genetically engineered pig models for human diseases. Ann Rev Anim Biosci 1:203–219. doi:10.1146/annurev-animal-031412-103715
Prescott MF, McBride CH, Hasler-Rapacz J, Von Linden J, Rapacz J (1991) Development of complex atherosclerotic lesions in pigs with inherited hyper-LDL cholesterolemia bearing mutant alleles for apolipoprotein B. Am J Pathol 139:139–147
Rapacz J, Hasler-Rapacz J, Taylor KM, Checovich WJ, Attie AD (1986) Lipoprotein mutations in pigs are associated with elevated plasma cholesterol and atherosclerosis. Science 234:1573–1577
Renner S et al (2010) Glucose intolerance and reduced proliferation of pancreatic beta-cells in transgenic pigs with impaired glucose-dependent insulinotropic polypeptide function. Diabetes 59:1228–1238. doi:10.2337/db09-0519
Renner S et al (2012) Changing metabolic signatures of amino acids and lipids during the prediabetic period in a pig model with impaired incretin function and reduced beta-cell mass. Diabetes 61:2166–2175. doi:10.2337/db11-1133
Renner S et al (2013) Permanent neonatal diabetes in INS(C94Y) transgenic pigs. Diabetes 62:1505–1511. doi:10.2337/db12-1065
Rivers L, Gaspar HB (2015) Severe combined immunodeficiency: recent developments and guidance on clinical management. Arch Dis Child. doi:10.1136/archdischild-2014-306425
Rogers CS et al (2008a) The porcine lung as a potential model for cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 295:L240–L263. doi:10.1152/ajplung.90203.2008
Rogers CS et al (2008b) Production of CFTR-null and CFTR-DeltaF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer. J Clin Invest 118:1571–1577. doi:10.1172/JCI34773
Rogers CS et al (2008c) Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 321:1837–1841. doi:10.1126/science.1163600
Rosen DR et al (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59–62. doi:10.1038/362059a0
Ross JW et al (2012) Generation of an inbred miniature pig model of retinitis pigmentosa. Invest Ophthalmol Vis Sci 53:501–507. doi:10.1167/iovs.11-8784
Sieren JC et al (2014) Development and translational imaging of a TP53 porcine tumorigenesis model. J Clin Investig 124:4052–4066. doi:10.1172/Jci75447
Sommer JR et al (2011) Production of ELOVL4 transgenic pigs: a large animal model for Stargardt-like macular degeneration. Br J Ophthalmol 95:1749–1754. doi:10.1136/bjophthalmol-2011-300417
Sondergaard LV, Ladewig J, Dagnaes-Hansen F, Herskin MS, Holm IE (2012) Object recognition as a measure of memory in 1–2 years old transgenic minipigs carrying the APPsw mutation for Alzheimer’s disease. Transgenic Res 21:1341–1348. doi:10.1007/s11248-012-9620-4
Steele PM, Chesebro JH, Stanson AW, Holmes DR Jr, Dewanjee MK, Badimon L, Fuster V (1985) Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. Circ Res 57:105–112
Stoltz DA et al (2010) Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth Science translational medicine 2:29ra31. doi:10.1126/scitranslmed.3000928
Stoltz DA, Meyerholz DK, Welsh MJ (2015) Origins of cystic fibrosis lung disease. N Engl J Med 372:351–362. doi:10.1056/NEJMra1300109
Stone EM, Sheffield VC, Hageman GS (2001) Molecular genetics of age-related macular degeneration. Hum Mol Genet 10:2285–2292
Streckel E et al (2015) Effects of the glucagon-like peptide-1 receptor agonist liraglutide in juvenile transgenic pigs modeling a pre-diabetic condition. J Transl Med 13:73. doi:10.1186/s12967-015-0431-2
Suzuki S et al (2012) Il2rg gene-targeted severe combined immunodeficiency pigs. Cell Stem Cell 10:753–758. doi:10.1016/j.stem.2012.04.021
Tan W, Carlson DF, Lancto CA, Garbe JR, Webster DA, Hackett PB, Fahrenkrug SC (2013) Efficient nonmeiotic allele introgression in livestock using custom endonucleases. Proc Natl Acad Sci USA 110:16526–16531. doi:10.1073/pnas.1310478110
Touznik A, Lee JJ, Yokota T (2014) New developments in exon skipping and splice modulation therapies for neuromuscular diseases. Expert Opin Biol Ther 14:809–819. doi:10.1517/14712598.2014.896335
Umeyama K et al (2009) Dominant-negative mutant hepatocyte nuclear factor 1alpha induces diabetes in transgenic-cloned pigs. Transgenic Res 18:697–706. doi:10.1007/s11248-009-9262-3
Verheule S et al (2004) Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1. Circ Res 94:1458–1465. doi:10.1161/01.RES.0000129579.59664.9d
Wallace GQ, McNally EM (2009) Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies. Annu Rev Physiol 71:37–57. doi:10.1146/annurev.physiol.010908.163216
Watanabe M et al (2013) Generation of interleukin-2 receptor gamma gene knockout pigs from somatic cells genetically modified by zinc finger nuclease-encoding mRNA. PLoS One 8:e76478. doi:10.1371/journal.pone.0076478
Welsh M, Ramsey B, Accurso F, Cutting G (2001) Cystic Fibrosis. In: Scriver CRBA, Sly WS, Valle D, Childs B, Vogelstein B (eds) The metabolic and molecular basis of inherited disease, 8th edn. McGraw-Hill, New York, pp 5121–5189
Wolf E, Braun-Reichhart C, Streckel E, Renner S (2014) Genetically engineered pig models for diabetes research. Transgenic Res 23:27–38. doi:10.1007/s11248-013-9755-y
Yang D et al (2010) Expression of Huntington’s disease protein results in apoptotic neurons in the brains of cloned transgenic pigs. Hum Mol Genet 19:3983–3994. doi:10.1093/hmg/ddq313
Yang H et al (2014) Species-dependent neuropathology in transgenic SOD1 pigs. Cell Res 24:464–481. doi:10.1038/cr.2014.25
Yao J et al (2014) Efficient bi-allelic gene knockout and site-specific knock-in mediated by TALENs in pigs. Sci Rep 4:6926. doi:10.1038/srep06926
Zhou X et al (2015) Generation of CRISPR/Cas9-mediated gene-targeted pigs via somatic cell nuclear transfer. Cell Mol Life Sci 72:1175–1184. doi:10.1007/s00018-014-1744-7
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rogers, C.S. Genetically engineered livestock for biomedical models. Transgenic Res 25, 345–359 (2016). https://doi.org/10.1007/s11248-016-9928-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11248-016-9928-6